Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotechnology Startup Investors in Austria in September 2025

Last updated: Sep 2025 A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotechnology startups based in Austria. We rank investors based on the number of investments they made in Biotechnology companies from Austria. We update this investor list every month.

Top 50 Biotechnology Startup Investors in Austria in September 2025

Investor	Biotechnology Austria investments
xista science ventures	10
xista science ventures	9
tecnet equity	6
austria Wirtschaftsservice (aws)	5
SOSV	5
MIG Capital	4
Schnidar Harald	3
aws Gründungsfonds	3
FPS-Holding	2
red-stars.com	2
Nina Capital	2
APEX Ventures	2
PUSH VC	2
Longevitytech.fund	2
Aescap Venture	2
APEX Ventures	2
Übermorgen Ventures	2
bmp Ventures	2
TSVC	2
Lansdowne Partners	2
10x Founders	2
R42 Group	2
Arax Capital Partners	2
The Austrian Research Promotion Agency (FFG)	2
BackBone Ventures	2
Matthias Wilrich	1
Santo Holding	1
ICL Planet Startup Hub	1
HCVC	1
ReGen Ventures	1
HackCapital	1
Tet Ventures	1
Possible Ventures	1
Auxxo	1
Andera Partners	1
Simon Capital	1
HBM Partners	1
Credit Agricole CIB	1
Die Wirtschaftskammer	1
MCI Capital SA	1
Kale United	1
eQventure	1
Gateway Ventures	1
Wlanholding GmbH	1
VP Venture Partners	1
4SC	1
Climentum Capital	1
Air Street Capital	1
NovaCapital	1
Sofinnova Partners	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Investment focus

Biotechnology, Medical, Medical Device
Seed, Pre-Seed, Series A
Austria, France, Slovenia

Portfolio highlights

Syntropic Medical GmbH — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.

Investment focus

Biotechnology, Medical, Software
Seed, Pre-Seed, Series A
Austria, Slovenia

Portfolio highlights

subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

Investment focus

Software, SaaS, Information Technology
Seed, Funding Round, Series A
Austria

Portfolio highlights

Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
Orderlion — Streamline your wholesale business with Orderlion's ordering app. Automate orders, boost sales, and enhance customer loyalty. Find out more!
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.

Investment focus

Software, Information Technology, SaaS
Seed, Grant, Pre-Seed
Austria, Belgium

Portfolio highlights

HD Immune — HD Immune develops an antibody to target the mutated protein and remove it from the body. HDI has a lead antibody mAB C6-17 which lowers mtHTT in the blood and organs.
Aitiologic — aitiologic is an Austrian precision medicine startup developing ai-powered solutions for early disease detection and targeted therapy.
Aileen Health — Next frame predictions for medical images.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Funding Round, Series B
Germany, France, Austria

Portfolio highlights

AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
ASTRA Therapeutics — Astra - Therapeutics

Entrepreneur, Angel Investor, Scientist and Inventor

Investment focus

mHealth, Software, Biopharma
Seed, Angel, Pre-Seed
Austria

Portfolio highlights

SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.

aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
Austria, United States, Germany

Portfolio highlights

Planted Green — Planted Green plants mixed forests to compensate for CO2 emissions.
Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."

SPV

Investment focus

Biotechnology, Health Diagnostics
Seed
Austria

Portfolio highlights

Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.

red-stars.com is an operative holding company that invests in and manages companies that provide mission-critical products and offerings to enable DIGITALIZATION and LIFE SCIENCES.

Investment focus

Software, Biotechnology, Telecommunications
Funding Round, Seed
Austria, Germany

Portfolio highlights

Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Investment focus

Health Care, Artificial Intelligence, Medical
Seed, Pre-Seed, Series A
United States, United Kingdom, Germany

Portfolio highlights

CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
EarlySight — EarlySight start-up company is founded in order to accelerate the development and to bring the technology to clinics.
Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.

APEX Ventures is a deep-tech and medical-focused venture capital firm.

Investment focus

Artificial Intelligence, Health Care, Software
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.

| Investments that move industries

Investment focus

Software, Apps, Information Technology
Seed, Series A, Funding Round
Austria, Germany, United States

Portfolio highlights

Podero — Podero's aim is to create software that controls energy devices, such as batteries, electric cars, and heat pumps, in order to lower CO2 emissions, create new revenue streams for utilities, and lower consumer electricity bills.Podero's objective is to make it possible to coordinate the largest fleet of devices in the world by utilizingtrade algorithms, software automation, and machine learning forecasts to move energy use to the most economical and sustainable times.
UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
Circonomit — Building the world's environmental data infrastructure - We are the sustainability counterpart to what Excel, Sheets and Datev are to financial planning and accounting. Our mission is to create the first decision intelligence platform to bridge sustainability and finance by building the global standard for the collection and aggregation ofcorporate environmental data.

Investing globally in technologies extending healthy lifespans

Investment focus

Biotechnology, Health Care, Personal Health
Seed, Convertible Note, Pre-Seed
United States, United Kingdom, The Netherlands

Portfolio highlights

Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.

The Aescap funds invest in the most promising innovative listed biotech companies with exceptional growth potential

Investment focus

Biotechnology, Pharmaceutical, Chemical
Series A, Series B, Funding Round
United Kingdom, Austria, Belgium

Portfolio highlights

Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja JÃ¤Ã¤ttela and Thomas Kirkegaard Jensen from the Danish Cancer Society (KrÃ¦ftens BekÃ¦mpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
Avantium — Build a sustainable future with Avantium. Leading the change in green chemistry and innovative solutions.
F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.

APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.

Investment focus

Artificial Intelligence, Health Care, Software
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.

We are an early stage VC for climate tech startups.

Investment focus

Software, Energy, Renewable Energy
Seed, Pre-Seed, Funding Round
Germany, Switzerland, Finland

Portfolio highlights

Ostrom — We make energy fair, smart and green - one flexible monthly plan with no hidden fees, digital-first and 100% renewable energy.
Green Fusion — Green Fusion is developing a cloud-based energy manager for the intelligent control of heat, electricity, and e-mobility. The focus here is on hybrid heating systems in buildings such as heat pumps + gas boilers and the coupling to photovoltaic systems and electric vehicle charging stations.
Zymvol Biomodeling — Need a new or better biocatalyst? At ZYMVOL we combine bioinformatics and molecular modeling to accelerate Enzyme Discovery and Design

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Investment focus

Software, Information Technology, Manufacturing
Seed, Funding Round, Series A
Germany, United States, Austria

Portfolio highlights

CYNiO — CYNiO is an innovative chemical startup dedicated to revolutionizing the production of isocyanates through a safe, flexible, and sustainable approach.
NorcSi GmbH — Entwicklung von neuartigen Batterietechnologien
byte robotics — Byte Robotics developed a springboard innovative software technology for robot program generation.

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Funding Round, Series A
United States, China, Canada

Portfolio highlights

Lumotive — Lumotive is a Seattle-based startup company developing high performance, solid-state lidar for autonomous systems in the automotive, UAV, robotics and related industries. The company's revolutionary beam-steering technology leverages Liquid Crystal Metasurfaces (or LCMs) implemented in mature semiconductor manufacturing processes to deliversmall, inexpensive 3D perception systems with unprecedented performance and reliability. For more information, visit us at www.lumotive.com.
Pearson Labs — Pearson Labs is a company that automates corporate transactions with AI, saving costs for law firms and businesses.
Carbon Free Energy Cloud — Carbon Credits Simplified

Fundamental Equity Investing, since 1998

Investment focus

Biotechnology, Machine Learning, Finance
Funding Round, Series A, Series B
United Kingdom, Austria, United States

Portfolio highlights

Nattergal — Nattergal is a company with a mission to deliver nature recovery at scale, to provide vital benefits for society and sustainable financial returns.
G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
AMNIS Treasury Services — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.

Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Pre-Seed
Germany, United States, United Kingdom

Portfolio highlights

Filics — A scalable transport solution for standardized load carriers with a minimum energy footprint
ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
FERNRIDE — Fernride enables automated, sustainable logistics by combining the skills of remote drivers with autonomous technologies.

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Investment focus

Biotechnology, Health Care, Information Technology
Seed, Funding Round, Pre-Seed
United Kingdom, United States, Austria

Portfolio highlights

Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.

ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment

Investment focus

Biotechnology, Health Care, Medical
Seed, Funding Round
Austria

Portfolio highlights

AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
Calyxha Biotechnologies GmbH — A new perspective on inflammation

The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.

Investment focus

Software, Artificial Intelligence, Health Care
Grant, Seed, Pre-Seed
Austria, United States, Belgium

Portfolio highlights

Chatlyn — Automated, AI-enhancend guest engagement, where your clients are most comfortable.
Synaps — The collaborative architectural platform where you can draw plans, delegate tasks and gather real-time feedback, all in one place. Join the waitlist.
Cycuria Therapeutics — While new therapies, such as FLT3 inhibitors and venetoclax-based regimens, have improved initial response rates, durable remissions and long-term survival

BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.

Investment focus

Information Technology, Artificial Intelligence, Software
Pre-Seed, Seed, Series A
Switzerland, Germany, Israel

Portfolio highlights

Aerospec — Aerospec offers comprehensive and actionable information that helps data-driven policymaking.
Reshape Systems — Reshape Systems designs AI-powered software solutions to automate, streamline and optimize production processes for manufacturers
RTDT Laboratories — Make real-time decisions to optimise fleet operation through unique structural health insights

Matthias Wilrich is the VP Vehicles and Supply Chain at TIER Mobility.

Investment focus

E-Commerce, Delivery Service, Mobile Apps
Seed, Pre-Seed, Series A
Germany, Austria, Malaysia

Portfolio highlights

Lumaly — Lumaly is a browser extension that automatically tries out and uses all available voucher codes in the cart when shopping online.
MAYD — MAYD provides telepharmacy platform providing healthcare-related goods in a convenient way by delivering it to doorstep.
HELLO INSIDE — HELLO INSIDE is a scientific self care company empowering people to have data-driven conversations with their bodies. Unlock your best self.

Santo Holding is a Zurich-based investment firm funding biotechnology, pharmaceutical, life sciences, and healthcare companies.

Investment focus

Biotechnology, Energy, Medical
Funding Round, Series B, Series C
Germany, Austria

Portfolio highlights

AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
SuppreMol — SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
Efficient Energy — Efficient Energy GmbH is an innovative manufacturer and system supplier of environmentally friendly refrigeration technology, based in Feldkirchen near Munich, Germany. The company developed the Bluezero-technology, which uses water as a refrigerant and and thereby entirely avoids fluorinated refrigerants (HFCs). Efficient Energy helps itscustomers overcome the increasing regulatory challenges of refrigeration technology, and offers them long-term, sustainable solutions with its eChiller model range. The eChiller chilled water units are ideally suited for process cooling, machine cooling and the cooling of technical equipment and data centres and provide cooling capacities from 35 kW to 120 kW, depending on the model. With its outstanding cost efficiency and low CO2 footprint, companies benefit on many fronts. The pioneering technology has also been noticed by politics and the media, and has received multiple awards for the eChiller. These include among others the European Business Award for the Environment 2018/2019 from the European Comission and the Red Herring Europe Top 100 in 2020.

ICL Startup Accelerator focuses on foodtech and crop nutrition startups, innovative products, and accelerates their market penetration

Investment focus

Biotechnology, Agriculture, Organic Food
Seed
Israel, Austria

Portfolio highlights

Lavie bio — LaVie Bio develops bacterial compositions that are sprayed on plants, used to coat seeds, or are integrated in the soil around the plant in order to improve the crop or the plant's features.
Arkeon Biotechnologies — Arkeon converts CO2 into resources to power tomorrow's industries.

HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.

Investment focus

Software, Robotics, Artificial Intelligence
Seed, Series A, Pre-Seed
United States, France, United Kingdom

Portfolio highlights

Karman+ — Mining near Earth asteroids
Alpine Eagle — The Sentinel Counter-UAS System is an air-to-air sensor & interceptor network designed to detect, classify, and intercept unmanned aerial systems (UAS)
Fuse Vectors — Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.

Investing in the ReGeneration

Investment focus

Agriculture, Biotechnology, Farming
Seed, Series A, Series B
United States, Austria, United Kingdom

Portfolio highlights

Anthrogen — Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
PACT — PACT designs Elegant materials produced in tune with the planet earth. It create revolutionary, sustainable biomaterials using the earth's resources, including collagen, herbal extracts, oils, and minerals.
Ulysses Ecosystem Engineering — Ulysses rewild the ocean and remove gigatons of carbon, contributing to global efforts to combat climate change and restore marine ecosystems.

Join FoodTech focused investors looking to back impact-driven founders shaping our food system

Investment focus

Biotechnology, Food and Beverage, Food Processing
Seed, Pre-Seed, Series A
United States, Israel, United Kingdom

Portfolio highlights

twig bio — twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.
Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence
UNCAGED Innovations — What if we could make leather without the animal? We are a biomaterials company combining the power of nature and technology to reimagine leather.

Tet Ventures is one of the most active global food-tech investors. We work with and invest in technology that can improve the food system.

Investment focus

Food and Beverage, Biotechnology, E-Commerce
Seed, Pre-Seed, Funding Round
United States, Germany, United Kingdom

Portfolio highlights

Afterlife Ag — Eliminate organic waste from going into landfills. Peat upcycles your food waste into fresh, sustainable, and delicious mushrooms.
FORAY bioscience — FORAY bioscience is a biotechnology company that uses biomanufacturing techniques to produce wood products.
Prolific Machines — Difficult protein production made simple. A next-generation expression system for next-generation therapeutics.

Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.

Investment focus

Software, Information Technology, Biotechnology
Seed, Pre-Seed, Series A
Germany, Australia, United States

Portfolio highlights

tozero — Truly bringing lithium-ion battery waste tozero by recovering all critical matierlas, like lithium, nickel, cobalt, manganese, and graphite.
HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
Hippos Exoskeleton — Hippos Exoskeleton created an auto-inflating knee brace to avoid tears in the ACL and other injuries.

The Auxxo Female Catalyst Fund is a sector agnostic pre-seed and seed stage investors that backs female (co-)founded startups in Europe.

Investment focus

Software, Health Care, FinTech
Seed, Pre-Seed, Series A
Germany, United Kingdom, France

Portfolio highlights

BIOVOX — Mit Biokunststoff aus nachwachsenden Rohstoffen bis zu 85% CO2 einsparen. Hergestellt unter ISO 13485, biokompatibel nach ISO 10993.
Recyda GmbH — All-in-one Packaging Recyclability Management
Exakt Health — Exakt Health is the physio app for sports injuries. The Exakt Health app guides users through self-diagnosis for frequent sports injuries and then creates an individualized rehabilitation plan.

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Investment focus

Biotechnology, Health Care, Medical
Series B, Private Equity, Funding Round
France, United States, Germany

Portfolio highlights

Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
Qualisteo — Qualisteo, a start-up company based in Nice specialised in smart grids company.
mylight150 — Mylight150 contributes to the creation of a society in which people generates own electricity to ensure self-sufficiency and long-term abundance.

Simon Capital is an early-stage VC fund with €105M capital ready to invest in innovations that will improve our everyday lives, following the mission of investing “for the next generation”.

Investment focus

Software, Biotechnology, SaaS
Seed, Series A, Series B
Germany, Austria

Portfolio highlights

Infinite Roots — Mushlabs is a biotech company using fermentation to create the next generation of sustainable foods from the roots of mushrooms.
Neople — Every employee deserves an assistant. Meet the Neople, and increase your productivity simply by starting a conversation with them. Trained on your documents, available in your pocket.
Pacifico Biolabs — Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of sustainable and food alternatives.

HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.

Investment focus

Biotechnology, Medical, Health Care
Series B, Funding Round, Series C
United States, Germany, Switzerland

Portfolio highlights

Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Mineralys Therapeutics — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from MitsubishiTanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension.

Crédit Agricole CIB specialises in the businesses of capital markets and investment and corporate banking.

Investment focus

Energy, Solar, Renewable Energy
Debt Financing, Series A, Post-IPO Debt
France, United States, United Kingdom

Portfolio highlights

CoreWeave — CoreWeave provides flexible compute services and products to empower innovators. The company provides GPU accelerated compute solutions to the CGI and machine learning industries. Backed by quality hardware and systems management infrastructure, CoreWeave is built to help clients scale and adapt to evolving compute requirements at industry leadingeconomics.
NEOM — THE LINE: THE FUTURE OF URBAN LIVING
Tipico Group — Tipico is the market provider of sports betting in Germany, with a strong position across other European markets as well. The company operates an innovative, digital multichannel offering with leading online and mobile portals, as well as more than 1,000 betting shops. As a premium brand, Tipico is able to offer a large range of bets whilecontinuing to uphold the highest standards in customer service and consumer protection. Tipico currently has more than 5,000 employees and operates in five countries.

The Austrian Federal Economic Chamber functions as the federal parent organization for the nine State Chambers and 110 trade associations for different industries within Austria's system of economy.

Investment focus

Software, Music, mHealth
Seed, Pre-Seed, Funding Round
Austria

Portfolio highlights

Music Traveler — Music Traveler is a rapidly growing aggregator and marketplace, bringing a highly fragmented B2B and B2BC environment to the sharing economy. Music Traveler centralises practice/rehearsal/performing spaces, equipment, and instruction for the performing arts – its mission is to promote the creation, appreciation and interest in music byy reducing barriers, facilitating new interactions.
The Apollinaire Group (TAG) — Intelligent supply chain management company.
SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.

MCI Capital is a leading Digital Private Equity investor in CEE, based in Warsaw, Poland. MCI Capital seeks to invest in digital disruption, transformation and infrastructure within EU, with focus on CEE. Preferred sectors are SaaS, E-commerce, Marketplace, Fintech, Insurtech, Foodtech, Traveltech and Digital Infrastructure. MCI typically investsEUR 25-100 M in a single project, either in Buyout or Expansion stage. Historically, MCI Capital has also been involved in funds dedicated to Private Debt, Growth and Venture Capital areas – these funds do not conduct any new investments, instead they focus on building the value of assets and de-investing.MCI Capital is managed by the executive management team. The company is listed on the Warsaw Stock Exchange since February 2001 and is also a member of the Polish Private Equity Association.

Investment focus

E-Commerce, Software, Mobile
Series A, Funding Round, Seed
Poland, Germany, United Kingdom

Portfolio highlights

IdoSell —
Gett — Gett is a technology platform focused on corporate Ground Transportation Management (GTM), where spend is estimated to exceed $100 billion globally. https://gett.com/why We are the GTM category leader, serving over a quarter of the Fortune 500 companies.Gett’s cloud-based software organizes thousands of transportation providers(corporate fleet, ride-hailing, taxi, and limos) into one single platform. The technology helps save businesses time and money by managing all their ground transportation spend, and optimizes the entire employee experience from booking and riding to invoicing and analytics.We are building the first ground transportation grid available to customers worldwide, similar to telephony and internet grids, with aspirations to become the standard in corporate ground transportation, just as Zoom became the standard in corporate communication.Founded in 2010 and headquartered in London, Gett has raised more than $750M in funding to date, including more than $300M from the Volkswagen Group. They employ over 800 employees globally.
ANSWEAR.com —

Kale United offers a portfolio of over 75+ plant-based game changers

Investment focus

Food and Beverage, Food Processing, Biotechnology
Seed, Pre-Seed, Funding Round
United Kingdom, Sweden, India

Portfolio highlights

Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
The Pack — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
Cultimate Foods — Cultimate Foods is a cellular agriculture company. It develops cultivated fat for hybrid alt-meat products. It's cultivated fat replicates the structure of animal fat tissue and it uses a "unique technological approach to 3D cultivation that creates the structure of their ingredient and reduces production costs."

Entrepreneurs for Entrepreneurs

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Funding Round
Austria, Switzerland

Portfolio highlights

Respory — Respory provides real-time people-tracking using proprietary radar sensors, all without capturing personal data. Our scalable sensor network, powered by AI-driven algorithms, delivers precise customer journey insights, critical for in-store performance in retail.
Teragon — Laser Metrology for Steel Rolling Mills. Engineered in Graz, Austria.
aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.

Gateway Ventures is Austria's biggest network of startup investors with currently over 4000 investors. We foster the Austrian and European startup eco-system by connecting investors and startups. Our startup portfolio covers FinTech, CleanTech, HeathTech, IT & Software, Big Data & Social Impact. We have financed >40 startups withseed fundings over € 30M+Gateway Ventures was founded in December 2015. Over 1000 investors and 200 partners are currently participating in the network, including European incubators, accelerators and VCs.https://www.gateway.ventures

Investment focus

Software, Information Technology, Apps
Seed, Series A, Funding Round
Germany, Austria, Estonia

Portfolio highlights

Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
Pilzling — Bio-Pilze direkt aus deiner Stadt.
LipoCheck — LipoCheck is a healthtech startup that focuses on improving the diagnosis and treatment of lipedema, a condition that affects millions of women. The company offers a digital platform that serves as a support system for patients and treating physicians. LipoCheck's services include helping patients recognize lipedema and providing assistance inbecoming symptom-free. The platform was developed with the experiences of practicing doctors, product managers, and software developers. In addition to its digital services, LipoCheck also offers a range of merchandise including hoodies and shirts.

Led by Werner Lanthaler, Wlanholding invests in life sciences and sustainability, advancing innovation and growth in cutting-edge technologies.

Investment focus

Medical, Health Care, Biotechnology
Seed
Austria

Portfolio highlights

aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.

VP Venture Partners is a venture capital firm invests in healthcare companies.

Investment focus

Medical, Health Care, Biotechnology
Seed
Austria

Portfolio highlights

aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.

4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.

Investment focus

Health Care, Biotechnology
Seed
Austria

Portfolio highlights

Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.

A Venture Capital firm investing into European early-stage tech companies attacking CO2 emissions

Investment focus

CleanTech, Clean Energy, Biotechnology
Seed, Series A, Series B
Sweden, Spain, Austria

Portfolio highlights

Qvantum — Qvantum is driven by a passion for a sustainable future and we are changing the way the cities of Europe are heated.
Scale Energy — Reduce your energy cost without any investment
Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.

Air Street Capital invests in AI-first companies.

Investment focus

Artificial Intelligence, Machine Learning, Biotechnology
Seed, Series A, Pre-Seed
United States, United Kingdom, Canada

Portfolio highlights

Sereact — Discover the world's easiest pick and place automation solution. Significant cost savings, productive 24/7, deployment in one day and no training required.
Fern Labs — Deploying agents at the scale of real world problems
Odyssey — We're pioneering world models, the next frontier of artificial intelligence.

NovaCapital invests in the union between entrepreneurs and innovation. It offers international and managerial experience, to transform innovative start-ups and already established companies into structured companies, with managerial skills and an international network.

Investment focus

Software, Artificial Intelligence, Information Technology
Seed, Pre-Seed, Series A
Italy, Austria

Portfolio highlights

EarlySight — EarlySight start-up company is founded in order to accelerate the development and to bring the technology to clinics.
BeDimensional — New Material Solution
Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

BetterOmics — The Omics AI Cloud
l`école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.

Investors by industry

Artificial intelligence

Climate

Consumer

Community